Sixth Affiliated Hospital, Sun Yat-sen University: Crohn Disease trials

The registry lists 34 Crohn Disease studies with Sixth Affiliated Hospital, Sun Yat-sen University as lead sponsor. 14 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 1Phase 2 2Phase 3 4Phase 4 5No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Endoscopic Stricturotomy Versus Balloon Dilation for Small Bowel Fibrotic Strictures in Crohn's DiseaseRecruitingNCT07833332Not applicable
• Prediction of Postoperative Recurrence in Crohn's DiseaseRecruitingNCT07824791
• IBD Biomarker Discovery and Validation PlatformRecruitingNCT07686406
• Real-World Study of IL-23 Inhibitors in Active Crohn's DiseaseRecruitingNCT07545317
• TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal ResponseRecruitingNCT07510191Phase 4
• Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's DiseaseRecruitingNCT07504510
• Efficacy and Safety of CDED With Anti-TNF-α Biologics in Crohn's DiseaseNot yet recruitingNCT07344428Not applicable
• Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and SafetyRecruitingNCT07216014Phase 4
• Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's DiseaseRecruitingNCT06902987Phase 1
• Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's DiseaseRecruitingNCT06520397Phase 4
• Endoscopic Balloon Dilatation Combined With PRP Injection in Colonic Stenosis in Crohn's DiseaseEnrolling by invitationNCT06165289Not applicable
• SIIT Based on UST CDST in Patients With CDRecruitingNCT05861167Phase 4
• HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's DiseaseNot yet recruitingNCT05813860Phase 4
• Endoscopic Stricturotomy Versus Endoscopic Balloon Dilatation in Patients With Crohn's Disease and Symptomatic Small Bowel StrictureRecruitingNCT05009212Not applicable
• Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests: A Single-Center Retrospective Cohort StudyCompletedNCT07644390
• Upadacitinib in Isolated Small Bowel Versus Non-Small Bowel Crohn's DiseaseCompletedNCT07597577
• MRI-Based Screening in a Retrospective Cohort Reveals Adverse Prognosis of Asymptomatic Perianal Fistulas in Crohn's Disease: A Long-term Follow-Up StudyCompletedNCT07555808
• Mesentery Guide Identify Microscopic Clean Resection and Reduces Crohn's Endoscopic RecurrenceCompletedNCT06550843
• Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's DiseaseCompletedNCT06446219
• Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's DiseaseCompletedNCT05815355
• Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging ScienceCompletedNCT05642247
• Multi-omics to Predict Responses to Biologics in IBDStatus unknownNCT05542459
• Study of Imaginomics Predicting Early Surgical Rates in Crohn's DiseaseCompletedNCT05174208
• Therapeutic Effect of New Biologics in Crohn's DiseaseCompletedNCT04923100
• Prospective Randomized Comparative Study of the Treatment of Multisegmental Fibrostenosing Crohn's Disease.Status unknownNCT04865484Not applicable
• N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's DiseaseStatus unknownNCT04761952Not applicable
• Upper Gastrointestinal Lesions in Crohn's DiseaseStatus unknownNCT03524144Not applicable
• The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CDStatus unknownNCT03393247Not applicable
• Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's DiseaseStatus unknownNCT03185624Phase 3
• Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's DiseaseStatus unknownNCT03185611Phase 3
• The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's DiseaseStatus unknownNCT03056664Phase 2/3
• Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD PatientsStatus unknownNCT02998827Not applicable
• Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using ThalidomideStatus unknownNCT02956538Early Phase 1
• The Efficiency of MSC in Refractory Crohn's DiseaseStatus unknownNCT02532738Phase 2/3